glp-1 and gip/glp-1 medications receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 Medications: Everything You Need

However, the absolute risk remains low, and the established benefits of these medications for diabetes and obesity management continue to outweigh this uncommon adverse event for most patients

Whether managing GLP-1 side effects, staying consistent during busy seasons or holidays, rebuilding routines after a setback, or celebrating progress in all its forms, these communities provide support from others who have shared experience and learnings

Use sunblock lotion or cream before getting exposed to the sun.

The IGFBP system exists for a reason

Qian, S

Highlights of Prescribing Information: Mounjaro (tirzepatide) Injection, for subcutaneous use